Mealy et al.
were combined under an atmosphere of argon and diluted with
32 mL of THF. After 15 min of stirring, the reaction vessel
was cooled to 0 °C, and 1.30 mL (20.8 mmol) of iodomethane
was added via syringe. The cooling bath was then removed,
and stirring was continued for 1 h. After concentration and
standard workup, 3.09 g (>100%) of 93% pure material was
obtained (remainder starting alcohol). Preparative GC (10 ft,
10% SE-30, 200 °C) afforded an analytically pure sample of
the title compound: 1H NMR (CDCl3) δ 7.32-7.31 (m, 1H),
7.26-7.21 (m, 3H), 4.24-4.16 (m, 2H), 3.47 (s, 3H), 3.09-2.96
(m, 2H), 2.39 (s, 6H); 13C NMR (CDCl3) δ 140.5, 139.5, 127.9,
1H), 3.16 (s, 3H), 3.14-3.06 (m, 1H), 2.97 (app sep, J ) 6.47
Hz, 1H), 2.24 (s, 3H), 1.07 (d, J ) 6.47 Hz, 3H), 1.02 (d, J )
6.47 Hz, 3H), 0.75 (d, J ) 6.87 Hz, 3H); 13C NMR (CDCl3) δ
141.6, 128.2, 128.1, 127.6, 87.2, 59.4, 56.9, 52.4, 32.6, 21.0, 20.0,
13.5; [R]27 ) +90.6 (c 4.40, CH2Cl2). Anal. Calcd for C14H23
-
D
NO: C, 75.97; H, 10.47; N, 6.33. Found: C, 75.59; H, 10.10;
N, 6.31.
N,N-Dia llyl-2-br om o-3-m eth yla n ilin e (36). Following the
general procedure of Tidwell and Buchwald,24 1.79 g (9.63
mmol) of 2-bromo-3-methylaniline,25 4.08 g (38.5 mmol) of
sodium carbonate, and 3.33 mL (38.5 mmol) of allyl bromide
were added to 40 mL of dry DMF, and the resulting mixture
was heated at reflux under an atmosphere of argon for 8 h.
Upon cooling, the salts were removed by filtration, and the
mother liquor was partitioned between diethyl ether and
water. The layers were separated, and the aqueous phase was
extracted twice with diethyl ether. The combined organic
layers were washed with water and brine, dried over magne-
sium sulfate, and concentrated. The crude yellow oil was
purified by Kugelrohr distillation to give 2.29 g (89%) of the
clear, slightly yellow oil: bp 82-86 °C (0.2 mm); 1H NMR
(CDCl3) δ 7.09 (apparent t, J ) 7.76 Hz, 1H), 6.94-6.86 (m,
2H), 5.89-5.76 (m, 2H), 5.21-5.07 (m, 4H), 3.66-3.64 (m, 4H),
2.41 (s, 3H); 13C NMR (CDCl3) δ 149.3, 139.6, 135.0, 126.5,
126.3, 126.2, 125.0, 82.9, 69.1, 57.6, 42.2, 37.0; [R]23 ) -96.7
D
(c 1.47, CH2Cl2). Anal. Calcd for C12H17NO: C, 75.35; H, 8.96;
N, 7.32. Found: C, 75.04; H, 8.83; N, 7.39.
(1S,2S)-(+)-N-Meth yl-O-eth ylpseu doeph edr in e (22). Fol-
lowing a modification of General Procedure B, a solution of
3.34 g (18.6 mmol) of (1S,2S)-(+)-N-methylpseudoephedrine19
in 37 mL of THF was treated with 5.22 g (46.6 mmol) of
potassium tert-butoxide for 15 min at 0 °C. A 3.48 mL (46.6
mmol) portion of ethyl bromide was added dropwise via
syringe, and the reaction mixture was allowed to stir at room
temperature for 1 h. After concentration and workup in the
usual way, 3.22 g (83%) of a clear, pale yellow oil was
obtained: bp 150 °C (6 mm); 1H NMR (CDCl3) δ 7.34-7.24
(m, 5H), 4.16 (d, J ) 8.60 Hz, 1H), 3.35-3.23 (m, 2H), 2.94-
2.87 (m, 1H), 2.39 (s, 6H), 1.14 (t, J ) 7.01 Hz, 3H), 0.66 (d, J
) 6.79 Hz, 3H); 13C NMR (CDCl3) δ 141.6, 128.1, 127.8, 127.5,
125.7, 124.4, 121.6, 117.4, 55.6, 24.2. Anal. Calcd for C13H16
-
NBr: C, 58.66; H, 6.06; N, 5.26. Found: C, 58.50; H, 6.08; N,
5.36.
84.1, 63.7, 63.5, 41.0, 15.3, 11.2; [R]27 ) +82.7 (c 7.35, CH2-
(()-1-Allyl-3,4-d im eth ylin d olin e (38). A solution of 323
mg (1.21 mmol) of N,N-diallyl-2-bromo-3-methylaniline (36)
in 10.9 mL of n-pentane and 1.2 mL of diethyl ether was cooled
to -78 °C under an atmosphere of argon, and 1.34 mL of a
1.99 M solution of t-BuLi in heptane (2.67 mmol) was added
dropwise over a 5 min period. The resulting mixture was
stirred at -78 °C for 10 min before addition of 0.40 mL (2.67
mmol) of TMEDA. After 10 min at -78 °C, the mixture was
transferred to a thermostated bath at -40 °C and stirred for
1.5 h before addition of 1.2 mL of dry, deoxygenated MeOH.
The reaction mixture was partitioned between 15 mL of water
and 15 mL of diethyl ether, and the organic portion was
washed with water, saturated aqueous ammonium chloride,
and brine. After drying over magnesium sulfate, concentration
by rotary evaporation gave 0.201 g (89%) of 85% pure indoline.
Preparative GC (10 ft, 10% FFAP, 200 °C) afforded analytically
pure clear and colorless oil: 1H NMR (CDCl3) δ 6.98 (apparent
t, J ) 7.70 Hz, 1H), 6.48 (d, J ) 7.56 Hz, 1H), 6.35 (d, J )
7.80 Hz, 1H), 5.94-5.84 (m, 1H), 5.29-5.23 (m, 1H), 5.18-
5.15 (m, 1H), 3.79 (m, 1H), 3.58 (m, 1H), 3.35 (apparent t, J )
8.49 Hz, 1H), 3.31-3.23 (m, 1H), 3.09 (dd, J ) 8.49, 2.61 Hz,
1H), 2.25 (s, 3H), 1.23 (d, J ) 6.84 Hz, 3H); 13C NMR (CDCl3)
δ 151.2, 134.3, 133.6, 133.4, 127.5, 119.5, 117.0, 105.0, 60.8,
51.8, 34.2, 19.0, 18.1. Anal. Calcd for C13H17N: C, 83.37; H,
9.15; N, 7.48. Found: C, 83.13; H, 9.51; N, 7.39.
P r epar ation of (S)-(+)-1-Allyl-3,4-dim eth ylin dolin e [(S)-
38]: An Un exp ected [2,3]-Sigm a tr op ic Rea r r a n gem en t
in th e P r esen ce of (-)-Sp a r tein e. A solution of 385 mg (1.45
mmol) of N,N-diallyl-2-bromo-3-methylaniline (36) in 13.1 mL
of n-pentane and 1.4 mL of diethyl ether was cooled to -78
°C under an atmosphere of argon, and 1.60 mL of a 1.99 M
solution of t-BuLi in heptane (3.18 mmol) was added dropwise
over a 5 min period. A white precipitate formed, and after 10
min at -78 °C 0.800 g (3.41 mmol) of (-)-sparteine was added
dropwise (the solution was noted to turn a cloudy yellow color).
The mixture was stirred for an additional 10 min at -78 °C,
the cooling bath was removed, and the solution was allowed
to stir for 7 h at room temperature before quench with 1.4 mL
of dry, deoxygenated MeOH. The mixture was partitioned
between water and pentane, and the organic portion was
washed with saturated aqueous ammonium chloride, and brine
D
Cl2); HRMS-FAB [M + 1]+ calcd for C13H22NO 208.1701, found
208.1707.
(1S,2S)-(+)-N-Eth yl-O-eth ylp seu d oep h ed r in e (23). The
amino ether was prepared by modification of General Proce-
dure B. Thus, a solution of 5.96 g (30.8 mmol) of (1S,2S)-(+)-
N-ethylpseudoephedrine23 in 123 mL of THF was treated with
8.63 g (77.0 mmol) of potassium tert-butoxide for 15 min at 0
°C. A 5.75 mL (77.0 mmol) portion of ethyl bromide was added
dropwise via syringe, and the reaction mixture was allowed
to warm to room temperature and stir for 1 h. After standard
workup and concentration, the crude product was found to be
a ∼7:3 mixture of product and starting material, as determined
by GC-MS analysis. This material was resubjected to the
conditions described above and purified in the usual way to
afford 4.64 g (68%) of a clear, pale yellow oil: bp 155 °C (3
mm); 1H NMR (CDCl3) δ 7.37-7.22 (m, 5H), 4.18 (d, J ) 8.43
Hz, 1H), 3.34-3.21 (m, 2H), 3.03-2.96 (m, 1H), 2.72-2.53 (m,
2H), 2.37 (s, 3H), 1.13 (t, J ) 7.01 Hz, 3H), 1.08 (t, J ) 7.14
Hz, 3H), 0.70 (d, J ) 6.84 Hz, 3H); 13C NMR (CDCl3) δ 142.0,
128.3, 128.0, 127.6, 84.7, 64.0, 62.7, 48.0, 37.7, 15.6, 14.1, 12.7;
[R]23 ) +92.4 (c 3.95, CH2Cl2). Anal. Calcd for C14H23NO: C,
D
75.97; H, 10.47; N, 6.33. Found: C, 75.71; H, 10.65; N, 6.51.
(1S,2S)-(+)-N-Eth yl-O-m eth ylpseu doeph edr in e (24). Fol-
lowing General Procedure B, 4.82 g (24.9 mmol) of (1S,2S)-
(+)-N-ethylpseudoephedrine23 afforded 3.95 g (77%) of the title
1
compound as a clear, pale yellow oil: bp 150 °C (3 mm); H
NMR (CDCl3) δ 7.37-7.24 (m, 5H), 4.03 (d, J ) 8.83 Hz, 1H),
3.14 (s, 3H), 3.05-2.98 (m, 1H), 2.70-2.61 (m, 1H), 2.54-2.46
(m, 1H), 2.33 (s, 3H), 1.10 (t, J ) 7.15 Hz, 3H), 0.64 (d, J )
6.80 Hz, 3H); 13C NMR (CDCl3) δ 141.2, 128.3, 127.9, 127.7,
86.4, 62.2, 56.5, 47.6, 37.3, 13.9, 10.7; [R]22 ) +103 (c 4.50,
D
CH2Cl2); HRMS-FAB [M + 1]+ calcd for C13H22NO 208.1701,
found 208.1711.
(1S,2S)-(+)-N-Isopr opyl-O-m eth ylpseu doeph edr in e (25).
Following General Procedure B, 4.11 g (19.8 mmol) of (1S,2S)-
(+)-N-isopropylpseudoephedrine23 afforded 2.16 g (49%) of the
title compound as a clear, pale yellow oil: bp 150 °C (2 mm);
1H NMR (CDCl3) δ 7.37-7.24 (m, 5H), 4.02 (d, J ) 7.60 Hz,
(22) For a description of the (1R,2S)-enantiomer, see: Senanayake,
C. H.; Bakale, R. P.; Fang, Q. K.; Grover, P. T.; Heefner, D. L.; Rossi,
R. F.; Wald, S. A. Preparation of Cycloalkylphenylglycolate Enantio-
mers by Asymmetric Synthesis. PCT Int. Appl. 9950205, 1999.
(23) For a description of the (1R,2R)-enantiomer, see: Enders, D.;
Zhu, J .; Kramps, L. Liebigs Ann./ Recueil. 1997, 6, 1101.
(24) Tidwell, J . H.; Buchwald, S. L. J . Am. Chem. Soc. 1994, 116,
11797.
(25) Krolski, M. E.; Renaldo, A. F.; Rudisill, D. E.; Stille, J . K. J .
Org. Chem. 1988, 53, 1170.
6048 J . Org. Chem., Vol. 69, No. 18, 2004